Evidence of diversity among epidemiologically related carbapenemase-producing Acinetobacter baumannii strains belonging to international clonal lineage II

Journal of Clinical Microbiology
Fabrizia MinandriPaolo Visca

Abstract

Carbapenem-resistant Acinetobacter baumannii strains belonging to international clonal lineage II (ICL-II) have become predominant in intensive care units (ICUs) throughout Italy. Between 2005 and 2009, the carbapenem-hydrolyzing class D β-lactamase (CHDL) bla(OXA-23) gene became more prevalent than bla(OXA-58) among epidemic ICL-II strains showing extensive genetic similarity. These findings posed the question of whether CHDL gene replacement occurred in the homogeneous ICL-II population or a new OXA-23 clone(s) emerged and spread in ICUs. In this study, the changes in the ICL-II A. baumannii population and CHDL gene carriage were investigated in 30 genetically related isolates collected during the bla(OXA-58)-to-bla(OXA-23) transition period. Pulsotyping, randomly amplified polymorphic DNA (RAPD) analysis, and multilocus sequence typing (MLST) results were combined with multilocus variable-number tandem-repeat (VNTR) analysis (MLVA-8), siderotyping, and plasmid profiling to improve genotype-based discrimination between isolates. Pulsotyping, RAPD analysis, and MLST clustered isolates into a single type. MLVA-8 identified 19 types that clustered into three complexes. All OXA-23-producing isolates formed a single complex, while...Continue Reading

References

Jan 1, 1987·Analytical Biochemistry·B Schwyn, J B Neilands
Mar 1, 1981·Journal of Bacteriology·C I Kado, S T Liu
Aug 1, 1994·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·H SeifertG Pulverer
Dec 6, 2002·Journal of Medical Microbiology·Richard P SpenceDavid M Livermore
Dec 8, 2004·Journal of Clinical Microbiology·Vincent RamisseGilles Vergnaud
Dec 24, 2004·Antimicrobial Agents and Chemotherapy·Laurent PoirelPatrice Nordmann
Sep 29, 2005·Antimicrobial Agents and Chemotherapy·Claire HéritierPatrice Nordmann
Apr 25, 2006·FEMS Microbiology Letters·Jane F TurtonT L Pitt
Aug 3, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Laurent Poirel, Patrice Nordmann
Jan 16, 2007·Antimicrobial Agents and Chemotherapy·Stéphane CorvecPatrice Nordmann
Apr 18, 2007·Antimicrobial Agents and Chemotherapy·Alessia BertiniAlessandra Carattoli
Jun 1, 2007·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Alessandra GiordanoAlessandra Carattoli
Jul 6, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Jane F TurtonT L Pitt
Nov 17, 2007·Nature Reviews. Microbiology·L DijkshoornHarald Seifert
Dec 21, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Kevin J TownerARPAC Steering Group
Jul 16, 2008·Clinical Microbiology Reviews·Anton Y PelegD L Paterson
Nov 21, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Jane F TurtonT L Pitt
Apr 29, 2009·Environmental Microbiology·Josselin BodilisPierre Cornelis
May 12, 2009·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Silvia D'ArezzoS Ziantoni
May 15, 2009·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·R E MendesG Fadda
Aug 25, 2009·The Journal of Hospital Infection·Kevin J Towner
Dec 25, 2009·Emerging Infectious Diseases·Pauline D MugnierPatrice Nordmann
May 12, 2010·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Anna Di PopoloRaffaele Zarrilli
Aug 10, 2011·Proceedings of the National Academy of Sciences of the United States of America·Evan S SnitkinJulie A Segre

Citations

Jul 20, 2014·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A PantelCARB-LR group
Jul 31, 2012·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Nabil KarahØrjan Samuelsen
Jan 13, 2016·The Journal of Antimicrobial Chemotherapy·Steven J Nigro, Ruth M Hall
Mar 24, 2016·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Aryann R GanjoWil Goessens
Nov 7, 2012·International Journal of Antimicrobial Agents·Raffaele ZarrilliA Tsakris
Jun 7, 2013·Journal of Medical Microbiology·Derek S SarovichDavid M Wagner
Jan 20, 2015·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Branka BedenićGernot E Zarfel
Dec 26, 2012·Diagnostic Microbiology and Infectious Disease·Roberta MigliavaccaFrancesco Luzzaro
Dec 24, 2014·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A PantelJ-P Lavigne
Jan 7, 2015·International Journal of Antimicrobial Agents·Paola Bocanegra-IbariasElvira Garza-González
Oct 3, 2014·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Mariagrazia PerilliGianfranco Amicosante
Sep 19, 2016·Diagnostic Microbiology and Infectious Disease·J Kristie JohnsonKerri A Thom
Jul 24, 2017·Journal of Global Antimicrobial Resistance·Ranko LadavacPaul G Higgins
May 11, 2017·Annals of Clinical Microbiology and Antimicrobials·Doaa Mohammad GhaithOmar Almoazzamy
Mar 7, 2021·International Journal of Environmental Research and Public Health·Andrea J GrisoldGernot E Zarfel

Related Concepts

Related Feeds

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

© 2021 Meta ULC. All rights reserved